A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma.
- Author:
Seok Jin KIM
1
Author Information
- Publication Type:Letter
- MeSH: Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Lymphoma, B-Cell; Rituximab
- From:Korean Journal of Hematology 2011;46(1):57-58
- CountryRepublic of Korea
- Language:English
- Abstract: No abstract available.
